Summary
HCC Chart
Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC
EMA Orphan Drug Designation (ODD) builds on U.S. Food & Drug Administration (FDA) ODD and Fast Track Designation, underscoring the urgent need for new treatment options The multiple regulatory designations were granted following strong positive results from a global randomized Phase 1b/2 study in first-line HCC demonstrating superior outcomes for amezalpat combination therapy across multiple study endpoints, including overall survival in both the entire population and key subpopulations, when compared to standard of care alone BRISBANE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted and immune-mediated therapeutics to fight cancer, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to amezalpat (TPST-1120), an oral, small molecule, selective PPAR⍺ antagonist for the treatment of patients with hepatocellular carcinoma (HCC).
Tokio Marine HCC and Susan G. Komen® Team Up Once Again with Golf Champion Nelly Korda to Help End Breast Cancer
This campaign aims to raise awareness of the high-quality care and services provided by Susan G. Komen to improve and save the lives of those impacted by breast cancer This campaign aims to raise awareness of the high-quality care and services provided by Susan G. Komen to improve and save the lives of those impacted by breast cancer
Somerset International Installs Six Tailings Dewatering Units at Warrior Met Coal's Blue Creek Mine, the Largest U.S. Coal Facility Without a Tailings Dam
PITTSBURGH--(BUSINESS WIRE)-- #Innovation--Somerset International has successfully deployed six state-of-the-art Tailings Dewatering systems at Warrior Met Coal's Blue Creek Mine.
Warrior Met Coal Inc. Dividends
 HCC In 1 month Estimated | Quarterly | $0.08 Per Share |
| HCC 1 month ago Paid | Quarterly | $0.08 Per Share |
| HCC 3 months ago Paid | Quarterly | $0.08 Per Share |
| HCC 7 months ago Paid | Quarterly | $0.08 Per Share |
| HCC 10 months ago Paid | Quarterly | $0.08 Per Share |
| HCC 3 May 2024 Paid | Quarterly | $0.08 Per Share |
Warrior Met Coal Inc. Earnings
| 30 Jul 2025 (52 Days) Date | | - Cons. EPS | - EPS |
| 29 Apr 2025 Date | | - Cons. EPS | - EPS |
| 12 Feb 2025 Date | | 0.46 Cons. EPS | 0.15 EPS |
| 30 Oct 2024 Date | | 0.75 Cons. EPS | 0.8 EPS |
| 1 Aug 2024 Date | | 1.34 Cons. EPS | 1.35 EPS |
| HCC In 1 month Estimated | Quarterly | $0.08 Per Share |
| HCC 1 month ago Paid | Quarterly | $0.08 Per Share |
| HCC 3 months ago Paid | Quarterly | $0.08 Per Share |
| HCC 7 months ago Paid | Quarterly | $0.08 Per Share |
| HCC 10 months ago Paid | Quarterly | $0.08 Per Share |
| HCC 3 May 2024 Paid | Quarterly | $0.08 Per Share |
| 30 Jul 2025 (52 Days) Date | | - Cons. EPS | - EPS |
| 29 Apr 2025 Date | | - Cons. EPS | - EPS |
| 12 Feb 2025 Date | | 0.46 Cons. EPS | 0.15 EPS |
| 30 Oct 2024 Date | | 0.75 Cons. EPS | 0.8 EPS |
| 1 Aug 2024 Date | | 1.34 Cons. EPS | 1.35 EPS |
Warrior Met Coal Inc. (HCC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Warrior Met Coal Inc. ever had a stock split?
Warrior Met Coal Inc. Profile
| Coal Industry | Energy Sector | Mr. Walter J. Scheller III CEO | NYSE Exchange | 93627C101 Cusip |
| US Country | 1,336 Employees | 5 May 2025 Last Dividend | - Last Split | 13 Apr 2017 IPO Date |
Overview
Warrior Met Coal, Inc. is a prominent player in the mining and production of non-thermal metallurgical coal, catering predominantly to the steel industry. Established in 2015 and headquartered in Brookwood, Alabama, the company operates two underground mines within the state. Warrior Met Coal is internationally recognized for its export activities, serving a diverse clientele of blast furnace steel producers across Europe, South America, and Asia. Alongside its primary coal production, the company also engages in the sale of natural gas, a byproduct derived from its coal mining operations.
Products and Services
- Non-thermal Metallurgical Coal
This type of coal is specifically used in the steel-making process. Warrior Met Coal’s metallurgical coal is prized for its high quality and efficiency in producing steel through the blast furnace method. The company’s dedication to this niche ensures a consistent supply to major steel producers worldwide.
- Natural Gas
Extracted as a byproduct from the coal production process, Warrior Met Coal also markets natural gas. This diversification not only enhances the company's product portfolio but also contributes to a more sustainable use of resources by utilizing byproducts effectively.
Contact Information
